glp-1 bone loss Therapy Risks: Muscle and Health Concerns | Darshan Shah posted on the topic GLP 1s for Weight Loss

The 2014 Beck Phase 2 randomised controlled trial published in the International Journal of Colorectal Disease provides the clinical-research-stage data point (PMID 25331030)

The distinction between FDA-approved GLP-1 medications further complicates Medicaid coverage: some state programs cover semaglutide (Ozempic/Wegovy) and tirzepatide (Zepbound/Mounjaro) while excluding newer compounds, or may cover injectable forms but not oral versions

Direct Provider Care Work directly with Josh Peterson, FNP-C

Inputs outputs Inputs: vial amount (usually mg), liquid added (mL), target amount (often mcg)

These medications are typically administered once or twice daily and are largely eliminated from the system within 24 hours